Vadim S. Koshkin

机构：University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center · ORCID：0000-0003-2277-8668

发表论文 328 篇 · 总被引 5543 次 · h-index 31

代表论文

• Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026 · Clinical Cancer Research · 被引 6)
• EV-PRIME: Phase Ib/II study of enfortumab vedotin and pembrolizumab combined with radiotherapy as a bladder-sparing trimodality therapy in muscle invasive bladder cancer. (2026 · Journal of Clinical Oncology · 被引 3)
• TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma (2026 · Future Oncology · 被引 2)
• RC48G001: A phase 2 study of disitamab vedotin in HER2-expressing previously treated advanced UC. (2026 · Journal of Clinical Oncology · 被引 2)
• Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab (2026 · European Urology Oncology · 被引 1)
• Longitudinal tumor-informed ctDNA monitoring and clinical outcomes in advanced urothelial carcinoma treated with enfortumab vedotin ± pembrolizumab. (2026 · Journal of Clinical Oncology · 被引 1)